Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

A series of antibacterial compounds described in patent literature

Jan. 14, 2005

Pfizer researchers report discovery of compounds with utility in diagnosis of CNS disorders

Jan. 14, 2005

Scientists at 3-Dimensional Pharmaceuticals present novel protein tyrosine kinase inhibitors

Jan. 14, 2005

A series of quinolones for the treatment of CNS disorders

Jan. 14, 2005

sanofi-aventis patent claims CCR2B receptor antagonists

Jan. 14, 2005

PDE4 inhibitors described by Merck Frosst

Jan. 14, 2005

Antiinfective agents claimed by GlaxoSmithKline

Jan. 13, 2005

Roche scientists prepare and test new agents for cancer

Jan. 13, 2005

GSK team identifies new 5-HT5A receptor ligands for CNS disorders

Jan. 13, 2005

HIV integrase inhibitors in early development at Bristol-Myers Squibb

Jan. 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...